Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure

BACKGROUND: Nucleos(t)ide analogues (NUCs) treatment can reduce the risk of hepatocellular carcinoma (HCC) development and recurrence in chronic hepatitis B (CHB) patients. However, the risk of recurrence in CHB patients who develop HCC despite NUC treatment remains unclear. METHODS: 167 consecutive...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Lee, I-Cheng, Chau, Gar-Yang, Yeh, Yi-Chen, Chao, Yee, Huo, Teh-Ia, Su, Chien-Wei, Lin, Han-Chieh, Hou, Ming-Chih, Huang, Yi-Hsiang
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2017
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5703552/
https://ncbi.nlm.nih.gov/pubmed/29176777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188552
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker